Effect of sarpogrelate hydrochloride on platelet-derived microparticles and various soluble adhesion molecules in diabetes mellitus

Clinical and Applied Thrombosis/Hemostasis

Volumn 6, Issue 3, 2000, Pages 139-143

  Shouzu, Akira ^a   Nomura, Shosaku ^a   Hayakawa, Takashi ^a   Omoto, Seitaro ^a   Shimizu, Hidekazu ^a   Miyake, Yutaka ^a   Yonemoto, Toshinaga ^a   Fukuhara, Shiro ^a   Iwasaka, Toshiji ^a   Nishikawa, Mitsushige ^a   Inada, Mitsuo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

CD62P; Diabetes mellitus; Platelet derived microparticles; Sarpogrelate hydrochloride; Soluble adhesion molecules

Indexed keywords

CD63 ANTIGEN; CELL ADHESION MOLECULE; GLUCOSE; PADGEM PROTEIN; SARPOGRELATE; THROMBOMODULIN; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; ENDOTHELIUM LESION; GLUCOSE BLOOD LEVEL; HUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ANTIGENS, CD; BLOOD PLATELETS; CELL ADHESION MOLECULES; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PLATELET MEMBRANE GLYCOPROTEINS; PROTEINURIA; REFERENCE VALUES; SUCCINATES; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0033836806     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960000600304     Document Type: Article

References (30)

1. Platelet function in diabetes mellitus
2. Red cell deformability, platelet aggregation, and insulin action
3. Isolation of human platelet membrane microparticles from plasma and serum
4. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor V a and express prothrombinase activity
5. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane
6. Detection and significance of platelet-membrane microparticles
7. Significance of platelet-derived microparticles in uremia
8. Influence of platelet-derived microparticles on coagulation in a lung cancer patient receiving chemotherapy
9. Thromboxane B2 formation and platelet sensitivity to prostacyclin in insulin-dependent and insulin-independent diabetics
10. Effect of platelet-derived microparticles for various actions of anti-coagulant agents in diabetic patients
11. Significance of various soluble adhesion molecules using anti-5HT2 agent before and after administration in diabetic patients
12. Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by near-normoglycemia
13. Activated platelets in subjects at increased risk of IDDM
14. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles
15. Atherosclerosis, the major complication of diabetes
16. Modulation by high glucose of adhesion molecule expression in cultured endothelial cells
17. Adhesion receptors of the immune system
18. Endothelial-leukocyte adhesion molecules
19. Elevated levels of circulating adhesion molecules in IDDM patients and in subjects at risk for IDDM
20. Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control
21. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: Relation to metabolic control
22. Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria: A marker of vascular dysfunction and progressive vascular disease
23. E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: Possible role of oxidative stress
24. Circulating adhesion molecules in disease
25. Elevated serum and urinary thrombomodulin levels in patients with non-insulin-dependent diabetes mellitus
26. Plasma thrombomodulin: A marker for microvascular complications in diabetes mellitus
27. 2-serotonergic receptor antagonist
28. The new selective antagonist of serotonergic (5-HT(2A)) receptors
29. Effect of cilostazol on soluble adhesion molecules and platelet-derived microparticles in patients with diabetes
30. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles